Korea has approved new combinations using Johnson & Johnson (J&J) Innovative Medicine’s Rybrevant (amivantamab), expanding ...

HLB has secured FDA for Lyrfigtu (lirafugratinib), an fibroblast growth factor receptor 2 (FGFR2)-targeted cancer drug for ...

Emergency physicians have strongly opposed a bill aimed at preventing hospitals from turning away emergency patients, saying ...

Onconic Therapeutics’ Chinese partner has dosed the first patient in a phase 3 trial of an injectable formulation of ...

For decades, radiologists have injected gadolinium-based contrast agents directly into patients’ joints for magnetic ...

Calls are growing for an overhaul of Korea’s disability assessment criteria for dwarfism, which critics say have direct ...

“I don’t want to lose my wife.”Patients with pulmonary arterial hypertension (PAH) and their families are urging the ...

A hospital has formally apologized to the family of a nurse who had reported workplace bullying before her death and agreed ...

Nineteen recipients of government public health scholarships have failed to complete their mandatory service without ...

Sepsis, a condition in which an abnormal, excessive immune response to infection damages major organs, is a medical emergency ...

Compass Therapeutics said Monday that U.S. regulators have recommended it run a trial showing a survival benefit before ...

As the government moves to formally introduce medication abortion, a National Assembly research body has called for drug ...